The latest news on MS treatments, research and specialist services.
MS Trust news
News from the MS Trust
Views and comment
MS Trust staff, MS health professionals and people with MS offer their perspectives on hot topics in the world of MS
Our free, quarterly newsletter for people with multiple sclerosis, their family and friends and supporters of the MS Trust.
Read our latest news
Pia Reynolds was born in Denmark, but has lived in the UK for 25 years. This year she joined our MS Forward View project, helping to represent the views of people living with MS. She’s also involved with our new MS nurse funding project.
In October 2016, Hasan trekked to the summmit of Mount Kilimanjaro, the tallest free-standing mountain in the world, to raise funds to support people with MS.
Today the MS Trust publishes the findings of its year-long MS Forward View project, looking at how MS services in the UK can deliver equitable, effective and efficient care for everyone living with MS.
The MS Trust's innovative interactive guide to disease modifying drugs, MS Decisions, was highly commended in the BMA Patient Information Awards.
Sarah and Phil have set up their own festive wear day on 14 December for anyone who is at home during the day.
Melissa tells us about her family's involvement with Tae Kwon-Do and why they are holding a sponsored kick to support the MS Trust.
The Scottish Medicines Consortium has announced that fampridine (Fampyra) is not a cost effective treatment for MS-related walking problems.
This evening at a ceremony in Windsor we were delighted to announce the winners of the second QuDoS awards, recognising quality in the delivery of MS services.
- Work capability assessment to be reviewed
- MS and breast cancer
- Living up north could speed up onset of MS
On Monday 31st October the government published its Work, Health and Disability Green Paper. (A Green Paper is a government consultation document. Its role is to create debate on proposals for new policy or legislation, before committing to a course of action.)
- ECTRIMS video highlights
- MS in the modern treatment era
- Biotin study results
- Nerves that affect postural control
Melissa tells us why she and her husband travelled 118 miles around Kent in a Nissan Cube, dressed in Halloween costumes.
- SNP backs decriminalising cannabis for medical use
- More MS nurses needed in West Yorkshire
- Tysabri (natalizumab) reduces depression in MS
- MS Society survey finds "disturbing levels" of workplace bullying
- Importance of family
Artist Becca Thomas, whose mother Rosemary recently passed away, is selling artworks in memory of her mum to help people with MS.
Bella and Charlie will be dressing as reindeer and taking part in a sponsored walk in honour of their dad Mike who has MS.
- How people with MS feel about risk
- Stress and onset of symptoms
- Lemtrada (alemtuzumab) and disability improvement
- Stress incontinence in women with MS
- Factors indicating how MS may develop
- Low dose naltrexone safety study
- Intimate relations
Further analysis of data from a clinical trial has shown that people taking Lemtrada were more likely to have an improvement in disability over the two years of the study, compared to people taking Rebif.
The MS Trust has created two relapse resources, one to support people living with MS and one for MS health professionals running relapse services.
What do early October, a church in London and Christmas cards have in common? They mark a very important event, as Claire from our fundraising team explains.
- ESA re-assessments
- NICE turns down daclizumab
- Mindfulness helps with coping
- Tysabri vs Gilenya comparison